MIMEDI: MIcrotechnique pour les MEDicaments Innovants nouvelles solutions technologiques pour optimiser la fabrication de "cellules médicaments"
Diaclone est partenaire d’un projet européen d’envergure associant une douzaine de partenaires de la région de Besançon.
Au sein de ce consortium, Diaclone apporte son expertise et son savoir-faire de plus de 30 ans dans le domaine des anticorps, afin d’aider à la mise en place de processus novateur en matière de tri cellulaire, de détection de contamination, de suivi de populations cellulaires, etc…
Now available - SARS-CoV-2 Spike RBD Variant Delta Publication date : 2021-07-27
Developed in our laboratories in Besançon (France)
#715-H25-0BU SARS-CoV-2 Spike RBD Variant Delta Lineage B.1.617.2
Read more
Medix Biochemica expands its monoclonal antibody offering through the acquisition of Diaclone Publication date : 2021-07-13
Medix Biochemica has acquired 100 percent of the shares of Diaclone, a prominent provider of monoclonal antibodies in the areas of inflammation, oncology and immunology.
Read more
Diaclone ELISpot assays, tried and trusted by researchers worldwide Publication date : 2021-04-01
Our BEST SELLER the IFNγ ELISpot assay, is widely used in clinical cancer studies and also in COVID-19 research
Read more
ELISpot Kits - A new format to meet your demands Publication date : 2021-02-25
The Diaclone ELISpot kit range is extended with a new 2 PLATE FORMAT
Read more
Monoclonal Antibody Platform Publication date : 2021-02-05
Diaclone and Seed Biosciences collaborate on the development of a new workflow for a faster and more efficient antibody development process
Read more
NEW!... RECOMBINANT HUMAN SARS-CoV-2 PROTEINS Publication date : 2020-10-15
Developed in our laboratories in Besançon (France)
Read more
Anti-S1 Domain Spike Protein is now available at Diaclone Publication date : 2020-08-03
What you need to know about Exosomes Publication date : 2020-07-01
“Huge opportunities”. “Many hurdles”. “Enormous potential”....
Read more
Fast track your Covid-19 Research with Diaclone’s CYTOKINES Publication date : 2020-05-18
Essential tools for Cytokine Storm monitoring & Immunotherapy development...
Read more
Essential tools for COVID-19 and Immunotherapy research Publication date : 2020-04-02
Diaclone provides a large panel of research tools, Monoclonal Antibodies and Immunoassays, for measuring the levels of released cytokines triggered by viral infection (cytokine release syndrome - CRS), including a complete range of human IL-6 and TNF-α products.
Read more
Human IL-6 cytokine, a useful tool for Coronavirus disease (COVID-19) and Immunotherapy research Publication date : 2020-03-20
DIACLONE provides a large panel of products for the quantification of human IL-6 and other human cytokines.
Read more
Use Diaclone’s Toolbox to monitor your CAR-T cell responses Publication date : 2019-12-16
In vitro studies with Diaclone’s Toolbox to monitor the risks linked to immunotherapy....
Read more
Diaclone's Toolbox for your Car-T Development Publication date : 2019-11-12
Our Monoclonal Antibodies and ELISpot range are valuable tools for your CAR-T research.
Read more
CAR-T development Publication date : 2019-10-01
How can Diaclone support your CAR-T development?
Read more
DIACLONE Assays for the Human IL-17 Family Publication date : 2019-08-28
Diaclone has developed a large range of ELISA and ELISpot kits for the detection of Human IL-17A, IL-17F and IL-17A/F.
Read more
The CAM family: A new target for monitoring or treating cancers? Publication date : 2019-08-28
The cell adhesion molecules (CAMs) family includes more than 50 proteins with four main groups: immunoglobulin (Ig)-like CAMs, cadherins, selectins, and integrins.
Read more
